Bray Capital Advisors decreased its position in UnitedHealth Group (NYSE:UNH) by 10.5% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 9,758 shares of the healthcare conglomerate’s stock after selling 1,144 shares during the quarter. Bray Capital Advisors’ holdings in UnitedHealth Group were worth $2,088,000 at the end of the most recent reporting period.
Several other institutional investors have also recently made changes to their positions in UNH. Geode Capital Management LLC raised its position in shares of UnitedHealth Group by 4.1% during the fourth quarter. Geode Capital Management LLC now owns 9,969,166 shares of the healthcare conglomerate’s stock worth $2,193,088,000 after purchasing an additional 395,090 shares during the period. Alliancebernstein L.P. raised its position in shares of UnitedHealth Group by 1.3% during the fourth quarter. Alliancebernstein L.P. now owns 7,334,593 shares of the healthcare conglomerate’s stock worth $1,616,984,000 after purchasing an additional 96,727 shares during the period. Jennison Associates LLC raised its position in shares of UnitedHealth Group by 10.2% during the fourth quarter. Jennison Associates LLC now owns 6,107,513 shares of the healthcare conglomerate’s stock worth $1,346,462,000 after purchasing an additional 565,536 shares during the period. Legal & General Group Plc raised its position in shares of UnitedHealth Group by 1.3% during the third quarter. Legal & General Group Plc now owns 5,153,894 shares of the healthcare conglomerate’s stock worth $1,009,355,000 after purchasing an additional 68,196 shares during the period. Finally, American Century Companies Inc. raised its position in shares of UnitedHealth Group by 3.5% during the first quarter. American Century Companies Inc. now owns 5,116,815 shares of the healthcare conglomerate’s stock worth $1,094,998,000 after purchasing an additional 173,074 shares during the period. Institutional investors and hedge funds own 87.11% of the company’s stock.
UNH has been the topic of a number of recent analyst reports. Argus boosted their target price on UnitedHealth Group to $270.00 and gave the stock a “buy” rating in a research report on Thursday, January 18th. Zacks Investment Research raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $267.00 price target on the stock in a research report on Saturday, January 20th. Barclays began coverage on UnitedHealth Group in a research report on Thursday, March 8th. They set an “overweight” rating and a $265.00 price target on the stock. Cantor Fitzgerald reissued a “buy” rating and set a $280.00 price target on shares of UnitedHealth Group in a research report on Thursday, March 8th. Finally, Credit Suisse Group reissued a “buy” rating on shares of UnitedHealth Group in a research report on Friday, March 9th. Two analysts have rated the stock with a hold rating and twenty-six have issued a buy rating to the company. The company presently has a consensus rating of “Buy” and an average price target of $253.70.
In other UnitedHealth Group news, CEO Steven H. Nelson sold 14,233 shares of the company’s stock in a transaction dated Thursday, March 15th. The stock was sold at an average price of $230.22, for a total value of $3,276,721.26. Following the transaction, the chief executive officer now directly owns 18,219 shares of the company’s stock, valued at approximately $4,194,378.18. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Director Richard T. Burke sold 10,000 shares of the company’s stock in a transaction dated Monday, March 19th. The stock was sold at an average price of $224.36, for a total value of $2,243,600.00. Following the completion of the transaction, the director now directly owns 1,771,257 shares in the company, valued at $397,399,220.52. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 72,019 shares of company stock worth $16,550,733. Insiders own 0.87% of the company’s stock.
Shares of UnitedHealth Group opened at $242.96 on Friday, Marketbeat reports. The company has a current ratio of 0.71, a quick ratio of 0.71 and a debt-to-equity ratio of 0.56. UnitedHealth Group has a fifty-two week low of $238.61 and a fifty-two week high of $240.48. The stock has a market capitalization of $230.16 billion, a price-to-earnings ratio of 24.13, a PEG ratio of 1.38 and a beta of 0.75.
UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, April 17th. The healthcare conglomerate reported $3.04 earnings per share for the quarter, topping the consensus estimate of $2.91 by $0.13. UnitedHealth Group had a return on equity of 22.06% and a net margin of 5.41%. The company had revenue of $55.19 billion for the quarter, compared to analyst estimates of $54.90 billion. During the same period in the prior year, the firm posted $2.37 EPS. The business’s revenue was up 13.3% compared to the same quarter last year. equities research analysts expect that UnitedHealth Group will post 12.61 earnings per share for the current fiscal year.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.